Dr. Santa-Maria is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 North Broadway Street
Viragh BLDG 10th FL
Baltimore, MD 21287Phone+1 410-955-8964Fax+1 410-367-2194
Summary
- Dr. Cesar Santa-Maria is an Oncology specialist based in Baltimore, MD, with a subspecialty in Breast Cancer. His education includes a fellowship in Hematology and Medical Oncology from Johns Hopkins University, a residency in Internal Medicine at University of Texas Southwestern Medical Center, and a MSCI at Northwestern. He is experienced in immunotherapy, breast cancer, and clinical research. Dr. Santa-Maria has published numerous studies, some of which have been cited by other publications. He has also overseen various clinical trials, often in the role of Principal Investigator or Study Chair.
Education & Training
NorthwesternMSCI, 2015 - 2017
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2011 - 2014
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2008 - 2011
McGovern Medical School at UTHealthClass of 2004
Certifications & Licensure
MD State Medical License 2011 - 2025
DC State Medical License 2019 - 2024
NC State Medical License 2020 - 2022
IL State Medical License 2014 - 2020- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer Start of enrollment: 2018 Nov 13
- Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer Start of enrollment: 2021 Jul 21
- Niraparib + Dostarlimab In BRCA Mutated Breast Cancer Start of enrollment: 2020 Dec 18
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Spatial Architecture of Single-Cell and Vasculature in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer.Haoyang Mi, Ravi Varadhan, Ashley M Cimino-Mathews, Leisha A Emens, Cesar A Santa-Maria
Modern Pathology. 2024-11-08 - Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade.Theinmozhi Arulraj, Hanwen Wang, Atul Deshpande, Ravi Varadhan, Leisha A Emens
Proceedings of the National Academy of Sciences of the United States of America. 2024-11-05 - Bi-level Graph Learning Unveils Prognosis-Relevant Tumor Microenvironment Patterns in Breast Multiplexed Digital Pathology.Zhenzhen Wang, Cesar A Santa-Maria, Aleksander S Popel, Jeremias Sulam
Biorxiv. 2024-10-04
Press Mentions
Computational Tool Predicts Immunotherapy Outcomes for Metastatic Breast Cancer PatientsOctober 31st, 2024- Computational Tool Predicts Immunotherapy Outcomes in Metastatic Triple-Negative Breast CancerOctober 30th, 2024
- Computational Tool Developed to Predict Immunotherapy Outcomes for Patients with Metastatic Breast CancerOctober 29th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
